KATHLEEN FOUCHE BRAZZLE: Open Payments
NPI 1629057906 · PONTIAC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,966 in 56 payments from 11 companies in 2025. Trend: 2023 $1,685 · 2024 $1,081 · 2025 $2,966
Food & beverage: $2,958Education: $8
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $624 |
| E.R. Squibb & Sons, L.L.C. | 11 | $478 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $406 |
| Axsome Therapeutics, Inc. | 7 | $353 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $219 |
| Lundbeck LLC | 5 | $189 |
| Teva Pharmaceuticals USA, Inc. | 4 | $185 |
| Supernus Pharmaceuticals, Inc. | 3 | $138 |
| ABBVIE INC. | 1 | $125 |
| Noven Therapeutics, LLC | 1 | $125 |
Products named: REXULTI, CAPLYTA, COBENFY, Auvelity, ABILIFY MAINTENA, AUSTEDO XR, Qelbree, VRAYLAR.
Industry payments across MI — which companies pay providers there.
